| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $44.9M | — | -18.8% |
| R&D Expense | $2.8M | — | -17.0% |
| SG&A Expense | $5.7M | — | -33.5% |
| Operating Income | -$3.9M | — | +44.8% |
| Interest Expense | $605K | — | -31.3% |
| Pre-tax Income | -$5.4M | — | +33.4% |
| Income Tax | $3K | — | -98.7% |
| Net Income | -$5.4M | — | +35.3% |
| EPS (Basic) | -$0.17 | — | +56.4% |
| EPS (Diluted) | -$0.17 | — | +56.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $10.3M | -20.4% | +113.3% |
| Accounts Receivable | $20.0M | -29.7% | -45.9% |
| Current Assets | $49.4M | -26.7% | -3.5% |
| Total Assets | $72.3M | -18.9% | -6.7% |
| Current Liabilities | $52.2M | -19.7% | +1.1% |
| Long-term Debt | $28.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $5.1M | — | +142.0% |
| Capital Expenditures | $57K | — | — |
| Investing Cash Flow | -$1.5M | — | +5.7% |
| Financing Cash Flow | -$6.3M | — | -21.6% |
| Free Cash Flow | $5.1M | — | +139.3% |
| +9.5% |
| Total Liabilities | $59.0M | -16.8% | +6.4% |
| Stockholders' Equity | $13.3M | -27.0% | -39.7% |